Research Articles | Page 80 | Aplastic Anemia & MDS International Foundation Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Randomized Phase III Study of Lenalidomide Versus Placebo in RBC Transfusion-Dependent Patients With Lower-Risk Non-del(5q) Myelodysplastic Syndromes and Ineligible for or Refractory to Erythropoiesis-Stimulating Agents Jun 2016 J Clin Oncol myelodysplastic syndromes (MDS)
Randomized trials with checkpoint inhibitors in acute myeloid leukaemia and myelodysplastic syndromes: What have we learned so far and where are we heading? Dec 2020 Best practice & research. Clinical haematology myelodysplastic syndromes (MDS)
Rational Management Approach To Pure Red Cell Aplasia Dec 2017 Haematologica pure red cell aplasia (PRCA)
Rationale for the Clinical Application of Flow Cytometry in Patients with Myelodysplastic Syndromes Aug 2012 Leuk Lymphoma myelodysplastic syndromes (MDS)
Ravulizumab: a novel C5 inhibitor for the treatment of paroxysmal nocturnal hemoglobinuria Sep 2019 Therapeutic Advances in Hematology paroxysmal nocturnal hemoglobinuria (PNH)
RBC transfusion independence among lower risk MDS patients receiving hypomethylating agents: a population-level analysis Jun 2019 Leukemia & Lymphoma myelodysplastic syndromes (MDS)
Real-Life experience with azacitidine in myelodysplastic syndromes according to IPSS cytogenetic profile Jan 2014 Am J Hematol myelodysplastic syndromes (MDS)
Recent advances in the management of therapy-related myelodysplastic syndromes and acute myeloid leukemia. Jan 2013 Curr Opin Hematol myelodysplastic syndromes (MDS)
Recent advances in the pathogenesis and treatment of paroxysmal nocturnal hemoglobinuria Feb 2016 F1000Res paroxysmal nocturnal hemoglobinuria (PNH)
Recent advances in the treatment of lower-risk non-del(5q) myelodysplastic syndromes (MDS) Nov 2016 Leuk Res myelodysplastic syndromes (MDS)
Share with addtoany.com.